0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Needle-free Drug Injectors Market Research Report 2026
Published Date: 2026-01-20
|
Report Code: QYRE-Auto-20D18907
Home | Market Reports | Business & Industrial| Energy & Utilities| Oil & Gas
Global Needle free Drug Injectors Market Research Report 2024
BUY CHAPTERS

Global Needle-free Drug Injectors Market Research Report 2026

Code: QYRE-Auto-20D18907
Report
2026-01-20
Pages:146
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Needle-free Drug Injectors Market Size

The global Needle-free Drug Injectors market was valued at US$ 246 million in 2025 and is anticipated to reach US$ 344 million by 2032, at a CAGR of 5.0% from 2026 to 2032.

Needle-free Drug Injectors Market

Needle-free Drug Injectors Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Needle-free Drug Injectors competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Needle-free drug injectors are advanced drug delivery technologies that dispense with the use of traditional syringes and needles in favor of the rapid delivery of drugs to subcutaneous or muscular tissues by means of high-speed liquid streams or other means that penetrate directly into the skin. These systems typically employ the high-pressure injection principle, which utilizes a compressed gas or spring-loaded device to generate sufficient pressure to allow the liquid drug to penetrate the skin barrier and enter the body in the form of an extremely fine, high-speed stream. Needle-free drug injectors are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
The North American market for Needle-free Drug Injectors is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Needle-free Drug Injectors is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Needle-free Drug Injectors include Halozyme (Antares Pharma), Inovio Pharmaceuticals, Endo International, Injex Pharma GmbH, National Medical Products (J-Tip), Recipharm, InsuJet, Miracle Medical, Medical International Technology (MIT), Akra Dermojet, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Needle-free Drug Injectors market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Needle-free Drug Injectors. The Needle-free Drug Injectors market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Needle-free Drug Injectors market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Needle-free Drug Injectors manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Needle-free Drug Injectors Market Report

Report Metric Details
Report Name Needle-free Drug Injectors Market
Accounted market size in 2025 US$ 246 million
Forecasted market size in 2032 US$ 344 million
CAGR 5.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Powder Injections
  • Liquid Injections
  • Depot or Projectile Injection
by Application
  • Vaccine Delivery
  • Insulin Delivery
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Halozyme (Antares Pharma), Inovio Pharmaceuticals, Endo International, Injex Pharma GmbH, National Medical Products (J-Tip), Recipharm, InsuJet, Miracle Medical, Medical International Technology (MIT), Akra Dermojet, PharmaJet, Portal Instruments, Crossject, Mika Medical, Ferring Pharmaceuticals, IntegriMedical, Helcomin, Nugen Medical, Lepu Medical, Beijing Quinovare, Qingdao Zhonghui Health Industrial Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Needle-free Drug Injectors manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Needle-free Drug Injectors sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Needle-free Drug Injectors Market growing?

Ans: The Needle-free Drug Injectors Market witnessing a CAGR of 5.0% during the forecast period 2026-2032.

What is the Needle-free Drug Injectors Market size in 2032?

Ans: The Needle-free Drug Injectors Market size in 2032 will be US$ 344 million.

Who are the main players in the Needle-free Drug Injectors Market report?

Ans: The main players in the Needle-free Drug Injectors Market are Halozyme (Antares Pharma), Inovio Pharmaceuticals, Endo International, Injex Pharma GmbH, National Medical Products (J-Tip), Recipharm, InsuJet, Miracle Medical, Medical International Technology (MIT), Akra Dermojet, PharmaJet, Portal Instruments, Crossject, Mika Medical, Ferring Pharmaceuticals, IntegriMedical, Helcomin, Nugen Medical, Lepu Medical, Beijing Quinovare, Qingdao Zhonghui Health Industrial Group

What are the Application segmentation covered in the Needle-free Drug Injectors Market report?

Ans: The Applications covered in the Needle-free Drug Injectors Market report are Vaccine Delivery, Insulin Delivery, Others

What are the Type segmentation covered in the Needle-free Drug Injectors Market report?

Ans: The Types covered in the Needle-free Drug Injectors Market report are Powder Injections, Liquid Injections, Depot or Projectile Injection

1 Needle-free Drug Injectors Market Overview
1.1 Product Definition
1.2 Needle-free Drug Injectors by Type
1.2.1 Global Needle-free Drug Injectors Market Value by Type: 2025 vs 2032
1.2.2 Powder Injections
1.2.3 Liquid Injections
1.2.4 Depot or Projectile Injection
1.3 Needle-free Drug Injectors by Application
1.3.1 Global Needle-free Drug Injectors Market Value by Application: 2025 vs 2032
1.3.2 Vaccine Delivery
1.3.3 Insulin Delivery
1.3.4 Others
1.4 Global Needle-free Drug Injectors Market Size Estimates and Forecasts
1.4.1 Global Needle-free Drug Injectors Revenue 2021–2032
1.4.2 Global Needle-free Drug Injectors Sales 2021–2032
1.4.3 Global Needle-free Drug Injectors Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Needle-free Drug Injectors Market Competition by Manufacturers
2.1 Global Needle-free Drug Injectors Sales Market Share by Manufacturers (2021–2026)
2.2 Global Needle-free Drug Injectors Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Needle-free Drug Injectors Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Needle-free Drug Injectors, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Needle-free Drug Injectors, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Needle-free Drug Injectors, Product Types and Applications
2.7 Global Key Manufacturers of Needle-free Drug Injectors, Date of Entry into the Industry
2.8 Global Needle-free Drug Injectors Market Competitive Situation and Trends
2.8.1 Global Needle-free Drug Injectors Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Needle-free Drug Injectors Players Market Share by Revenue
2.8.3 Global Needle-free Drug Injectors Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Needle-free Drug Injectors Market Scenario by Region
3.1 Global Needle-free Drug Injectors Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Needle-free Drug Injectors Sales by Region: 2021–2032
3.2.1 Global Needle-free Drug Injectors Sales by Region: 2021–2026
3.2.2 Global Needle-free Drug Injectors Sales by Region: 2027–2032
3.3 Global Needle-free Drug Injectors Revenue by Region: 2021–2032
3.3.1 Global Needle-free Drug Injectors Revenue by Region: 2021–2026
3.3.2 Global Needle-free Drug Injectors Revenue by Region: 2027–2032
3.4 North America Needle-free Drug Injectors Market Facts & Figures by Country
3.4.1 North America Needle-free Drug Injectors Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Needle-free Drug Injectors Sales by Country (2021–2032)
3.4.3 North America Needle-free Drug Injectors Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Needle-free Drug Injectors Market Facts & Figures by Country
3.5.1 Europe Needle-free Drug Injectors Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Needle-free Drug Injectors Sales by Country (2021–2032)
3.5.3 Europe Needle-free Drug Injectors Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Needle-free Drug Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific Needle-free Drug Injectors Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Needle-free Drug Injectors Sales by Region (2021–2032)
3.6.3 Asia Pacific Needle-free Drug Injectors Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Needle-free Drug Injectors Market Facts & Figures by Country
3.7.1 Latin America Needle-free Drug Injectors Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Needle-free Drug Injectors Sales by Country (2021–2032)
3.7.3 Latin America Needle-free Drug Injectors Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Needle-free Drug Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa Needle-free Drug Injectors Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Needle-free Drug Injectors Sales by Country (2021–2032)
3.8.3 Middle East and Africa Needle-free Drug Injectors Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Needle-free Drug Injectors Sales by Type (2021–2032)
4.1.1 Global Needle-free Drug Injectors Sales by Type (2021–2026)
4.1.2 Global Needle-free Drug Injectors Sales by Type (2027–2032)
4.1.3 Global Needle-free Drug Injectors Sales Market Share by Type (2021–2032)
4.2 Global Needle-free Drug Injectors Revenue by Type (2021–2032)
4.2.1 Global Needle-free Drug Injectors Revenue by Type (2021–2026)
4.2.2 Global Needle-free Drug Injectors Revenue by Type (2027–2032)
4.2.3 Global Needle-free Drug Injectors Revenue Market Share by Type (2021–2032)
4.3 Global Needle-free Drug Injectors Price by Type (2021–2032)
5 Segment by Application
5.1 Global Needle-free Drug Injectors Sales by Application (2021–2032)
5.1.1 Global Needle-free Drug Injectors Sales by Application (2021–2026)
5.1.2 Global Needle-free Drug Injectors Sales by Application (2027–2032)
5.1.3 Global Needle-free Drug Injectors Sales Market Share by Application (2021–2032)
5.2 Global Needle-free Drug Injectors Revenue by Application (2021–2032)
5.2.1 Global Needle-free Drug Injectors Revenue by Application (2021–2026)
5.2.2 Global Needle-free Drug Injectors Revenue by Application (2027–2032)
5.2.3 Global Needle-free Drug Injectors Revenue Market Share by Application (2021–2032)
5.3 Global Needle-free Drug Injectors Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Halozyme (Antares Pharma)
6.1.1 Halozyme (Antares Pharma) Company Information
6.1.2 Halozyme (Antares Pharma) Description and Business Overview
6.1.3 Halozyme (Antares Pharma) Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Halozyme (Antares Pharma) Needle-free Drug Injectors Product Portfolio
6.1.5 Halozyme (Antares Pharma) Recent Developments/Updates
6.2 Inovio Pharmaceuticals
6.2.1 Inovio Pharmaceuticals Company Information
6.2.2 Inovio Pharmaceuticals Description and Business Overview
6.2.3 Inovio Pharmaceuticals Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Inovio Pharmaceuticals Needle-free Drug Injectors Product Portfolio
6.2.5 Inovio Pharmaceuticals Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Company Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Endo International Needle-free Drug Injectors Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Injex Pharma GmbH
6.4.1 Injex Pharma GmbH Company Information
6.4.2 Injex Pharma GmbH Description and Business Overview
6.4.3 Injex Pharma GmbH Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Injex Pharma GmbH Needle-free Drug Injectors Product Portfolio
6.4.5 Injex Pharma GmbH Recent Developments/Updates
6.5 National Medical Products (J-Tip)
6.5.1 National Medical Products (J-Tip) Company Information
6.5.2 National Medical Products (J-Tip) Description and Business Overview
6.5.3 National Medical Products (J-Tip) Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 National Medical Products (J-Tip) Needle-free Drug Injectors Product Portfolio
6.5.5 National Medical Products (J-Tip) Recent Developments/Updates
6.6 Recipharm
6.6.1 Recipharm Company Information
6.6.2 Recipharm Description and Business Overview
6.6.3 Recipharm Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Recipharm Needle-free Drug Injectors Product Portfolio
6.6.5 Recipharm Recent Developments/Updates
6.7 InsuJet
6.7.1 InsuJet Company Information
6.7.2 InsuJet Description and Business Overview
6.7.3 InsuJet Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 InsuJet Needle-free Drug Injectors Product Portfolio
6.7.5 InsuJet Recent Developments/Updates
6.8 Miracle Medical
6.8.1 Miracle Medical Company Information
6.8.2 Miracle Medical Description and Business Overview
6.8.3 Miracle Medical Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Miracle Medical Needle-free Drug Injectors Product Portfolio
6.8.5 Miracle Medical Recent Developments/Updates
6.9 Medical International Technology (MIT)
6.9.1 Medical International Technology (MIT) Company Information
6.9.2 Medical International Technology (MIT) Description and Business Overview
6.9.3 Medical International Technology (MIT) Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Medical International Technology (MIT) Needle-free Drug Injectors Product Portfolio
6.9.5 Medical International Technology (MIT) Recent Developments/Updates
6.10 Akra Dermojet
6.10.1 Akra Dermojet Company Information
6.10.2 Akra Dermojet Description and Business Overview
6.10.3 Akra Dermojet Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Akra Dermojet Needle-free Drug Injectors Product Portfolio
6.10.5 Akra Dermojet Recent Developments/Updates
6.11 PharmaJet
6.11.1 PharmaJet Company Information
6.11.2 PharmaJet Description and Business Overview
6.11.3 PharmaJet Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 PharmaJet Needle-free Drug Injectors Product Portfolio
6.11.5 PharmaJet Recent Developments/Updates
6.12 Portal Instruments
6.12.1 Portal Instruments Company Information
6.12.2 Portal Instruments Description and Business Overview
6.12.3 Portal Instruments Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Portal Instruments Needle-free Drug Injectors Product Portfolio
6.12.5 Portal Instruments Recent Developments/Updates
6.13 Crossject
6.13.1 Crossject Company Information
6.13.2 Crossject Description and Business Overview
6.13.3 Crossject Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Crossject Needle-free Drug Injectors Product Portfolio
6.13.5 Crossject Recent Developments/Updates
6.14 Mika Medical
6.14.1 Mika Medical Company Information
6.14.2 Mika Medical Description and Business Overview
6.14.3 Mika Medical Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Mika Medical Needle-free Drug Injectors Product Portfolio
6.14.5 Mika Medical Recent Developments/Updates
6.15 Ferring Pharmaceuticals
6.15.1 Ferring Pharmaceuticals Company Information
6.15.2 Ferring Pharmaceuticals Description and Business Overview
6.15.3 Ferring Pharmaceuticals Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Ferring Pharmaceuticals Needle-free Drug Injectors Product Portfolio
6.15.5 Ferring Pharmaceuticals Recent Developments/Updates
6.16 IntegriMedical
6.16.1 IntegriMedical Company Information
6.16.2 IntegriMedical Description and Business Overview
6.16.3 IntegriMedical Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 IntegriMedical Needle-free Drug Injectors Product Portfolio
6.16.5 IntegriMedical Recent Developments/Updates
6.17 Helcomin
6.17.1 Helcomin Company Information
6.17.2 Helcomin Description and Business Overview
6.17.3 Helcomin Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Helcomin Needle-free Drug Injectors Product Portfolio
6.17.5 Helcomin Recent Developments/Updates
6.18 Nugen Medical
6.18.1 Nugen Medical Company Information
6.18.2 Nugen Medical Description and Business Overview
6.18.3 Nugen Medical Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Nugen Medical Needle-free Drug Injectors Product Portfolio
6.18.5 Nugen Medical Recent Developments/Updates
6.19 Lepu Medical
6.19.1 Lepu Medical Company Information
6.19.2 Lepu Medical Description and Business Overview
6.19.3 Lepu Medical Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Lepu Medical Needle-free Drug Injectors Product Portfolio
6.19.5 Lepu Medical Recent Developments/Updates
6.20 Beijing Quinovare
6.20.1 Beijing Quinovare Company Information
6.20.2 Beijing Quinovare Description and Business Overview
6.20.3 Beijing Quinovare Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Beijing Quinovare Needle-free Drug Injectors Product Portfolio
6.20.5 Beijing Quinovare Recent Developments/Updates
6.21 Qingdao Zhonghui Health Industrial Group
6.21.1 Qingdao Zhonghui Health Industrial Group Company Information
6.21.2 Qingdao Zhonghui Health Industrial Group Description and Business Overview
6.21.3 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product Portfolio
6.21.5 Qingdao Zhonghui Health Industrial Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Needle-free Drug Injectors Industry Chain Analysis
7.2 Needle-free Drug Injectors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Needle-free Drug Injectors Production Mode & Process Analysis
7.4 Needle-free Drug Injectors Sales and Marketing
7.4.1 Needle-free Drug Injectors Sales Channels
7.4.2 Needle-free Drug Injectors Distributors
7.5 Needle-free Drug Injectors Customer Analysis
8 Needle-free Drug Injectors Market Dynamics
8.1 Needle-free Drug Injectors Industry Trends
8.2 Needle-free Drug Injectors Market Drivers
8.3 Needle-free Drug Injectors Market Challenges
8.4 Needle-free Drug Injectors Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Needle-free Drug Injectors Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Needle-free Drug Injectors Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Needle-free Drug Injectors Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Needle-free Drug Injectors Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Needle-free Drug Injectors Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Needle-free Drug Injectors Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Needle-free Drug Injectors Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Needle-free Drug Injectors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Needle-free Drug Injectors, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Needle-free Drug Injectors, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Needle-free Drug Injectors, Product Types and Applications
 Table 12. Global Key Manufacturers of Needle-free Drug Injectors, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Needle-free Drug Injectors Companies by Tier (Tier 1, Tier 2, Tier 3), based on Needle-free Drug Injectors Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Needle-free Drug Injectors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Needle-free Drug Injectors Sales by Region (K Units), 2021–2026
 Table 18. Global Needle-free Drug Injectors Sales Market Share by Region (2021–2026)
 Table 19. Global Needle-free Drug Injectors Sales by Region (K Units), 2027–2032
 Table 20. Global Needle-free Drug Injectors Sales Market Share by Region (2027–2032)
 Table 21. Global Needle-free Drug Injectors Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Needle-free Drug Injectors Revenue Market Share by Region (2021–2026)
 Table 23. Global Needle-free Drug Injectors Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Needle-free Drug Injectors Revenue Market Share by Region (2027–2032)
 Table 25. North America Needle-free Drug Injectors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Needle-free Drug Injectors Sales by Country (K Units), 2021–2026
 Table 27. North America Needle-free Drug Injectors Sales by Country (K Units), 2027–2032
 Table 28. North America Needle-free Drug Injectors Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Needle-free Drug Injectors Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Needle-free Drug Injectors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Needle-free Drug Injectors Sales by Country (K Units), 2021–2026
 Table 32. Europe Needle-free Drug Injectors Sales by Country (K Units), 2027–2032
 Table 33. Europe Needle-free Drug Injectors Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Needle-free Drug Injectors Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Needle-free Drug Injectors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Needle-free Drug Injectors Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Needle-free Drug Injectors Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Needle-free Drug Injectors Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Needle-free Drug Injectors Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Needle-free Drug Injectors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Needle-free Drug Injectors Sales by Country (K Units), 2021–2026
 Table 42. Latin America Needle-free Drug Injectors Sales by Country (K Units), 2027–2032
 Table 43. Latin America Needle-free Drug Injectors Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Needle-free Drug Injectors Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Needle-free Drug Injectors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Needle-free Drug Injectors Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Needle-free Drug Injectors Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Needle-free Drug Injectors Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Needle-free Drug Injectors Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Needle-free Drug Injectors Sales (K Units) by Type (2021–2026)
 Table 51. Global Needle-free Drug Injectors Sales (K Units) by Type (2027–2032)
 Table 52. Global Needle-free Drug Injectors Sales Market Share by Type (2021–2026)
 Table 53. Global Needle-free Drug Injectors Sales Market Share by Type (2027–2032)
 Table 54. Global Needle-free Drug Injectors Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Needle-free Drug Injectors Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Needle-free Drug Injectors Revenue Market Share by Type (2021–2026)
 Table 57. Global Needle-free Drug Injectors Revenue Market Share by Type (2027–2032)
 Table 58. Global Needle-free Drug Injectors Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Needle-free Drug Injectors Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Needle-free Drug Injectors Sales (K Units) by Application (2021–2026)
 Table 61. Global Needle-free Drug Injectors Sales (K Units) by Application (2027–2032)
 Table 62. Global Needle-free Drug Injectors Sales Market Share by Application (2021–2026)
 Table 63. Global Needle-free Drug Injectors Sales Market Share by Application (2027–2032)
 Table 64. Global Needle-free Drug Injectors Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Needle-free Drug Injectors Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Needle-free Drug Injectors Revenue Market Share by Application (2021–2026)
 Table 67. Global Needle-free Drug Injectors Revenue Market Share by Application (2027–2032)
 Table 68. Global Needle-free Drug Injectors Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Needle-free Drug Injectors Price (US$/Unit) by Application (2027–2032)
 Table 70. Halozyme (Antares Pharma) Company Information
 Table 71. Halozyme (Antares Pharma) Description and Business Overview
 Table 72. Halozyme (Antares Pharma) Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Halozyme (Antares Pharma) Needle-free Drug Injectors Product
 Table 74. Halozyme (Antares Pharma) Recent Developments/Updates
 Table 75. Inovio Pharmaceuticals Company Information
 Table 76. Inovio Pharmaceuticals Description and Business Overview
 Table 77. Inovio Pharmaceuticals Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Inovio Pharmaceuticals Needle-free Drug Injectors Product
 Table 79. Inovio Pharmaceuticals Recent Developments/Updates
 Table 80. Endo International Company Information
 Table 81. Endo International Description and Business Overview
 Table 82. Endo International Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Endo International Needle-free Drug Injectors Product
 Table 84. Endo International Recent Developments/Updates
 Table 85. Injex Pharma GmbH Company Information
 Table 86. Injex Pharma GmbH Description and Business Overview
 Table 87. Injex Pharma GmbH Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Injex Pharma GmbH Needle-free Drug Injectors Product
 Table 89. Injex Pharma GmbH Recent Developments/Updates
 Table 90. National Medical Products (J-Tip) Company Information
 Table 91. National Medical Products (J-Tip) Description and Business Overview
 Table 92. National Medical Products (J-Tip) Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. National Medical Products (J-Tip) Needle-free Drug Injectors Product
 Table 94. National Medical Products (J-Tip) Recent Developments/Updates
 Table 95. Recipharm Company Information
 Table 96. Recipharm Description and Business Overview
 Table 97. Recipharm Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Recipharm Needle-free Drug Injectors Product
 Table 99. Recipharm Recent Developments/Updates
 Table 100. InsuJet Company Information
 Table 101. InsuJet Description and Business Overview
 Table 102. InsuJet Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. InsuJet Needle-free Drug Injectors Product
 Table 104. InsuJet Recent Developments/Updates
 Table 105. Miracle Medical Company Information
 Table 106. Miracle Medical Description and Business Overview
 Table 107. Miracle Medical Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Miracle Medical Needle-free Drug Injectors Product
 Table 109. Miracle Medical Recent Developments/Updates
 Table 110. Medical International Technology (MIT) Company Information
 Table 111. Medical International Technology (MIT) Description and Business Overview
 Table 112. Medical International Technology (MIT) Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Medical International Technology (MIT) Needle-free Drug Injectors Product
 Table 114. Medical International Technology (MIT) Recent Developments/Updates
 Table 115. Akra Dermojet Company Information
 Table 116. Akra Dermojet Description and Business Overview
 Table 117. Akra Dermojet Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Akra Dermojet Needle-free Drug Injectors Product
 Table 119. Akra Dermojet Recent Developments/Updates
 Table 120. PharmaJet Company Information
 Table 121. PharmaJet Description and Business Overview
 Table 122. PharmaJet Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. PharmaJet Needle-free Drug Injectors Product
 Table 124. PharmaJet Recent Developments/Updates
 Table 125. Portal Instruments Company Information
 Table 126. Portal Instruments Description and Business Overview
 Table 127. Portal Instruments Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Portal Instruments Needle-free Drug Injectors Product
 Table 129. Portal Instruments Recent Developments/Updates
 Table 130. Crossject Company Information
 Table 131. Crossject Description and Business Overview
 Table 132. Crossject Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Crossject Needle-free Drug Injectors Product
 Table 134. Crossject Recent Developments/Updates
 Table 135. Mika Medical Company Information
 Table 136. Mika Medical Description and Business Overview
 Table 137. Mika Medical Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Mika Medical Needle-free Drug Injectors Product
 Table 139. Mika Medical Recent Developments/Updates
 Table 140. Ferring Pharmaceuticals Company Information
 Table 141. Ferring Pharmaceuticals Description and Business Overview
 Table 142. Ferring Pharmaceuticals Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Ferring Pharmaceuticals Needle-free Drug Injectors Product
 Table 144. Ferring Pharmaceuticals Recent Developments/Updates
 Table 145. IntegriMedical Company Information
 Table 146. IntegriMedical Description and Business Overview
 Table 147. IntegriMedical Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. IntegriMedical Needle-free Drug Injectors Product
 Table 149. IntegriMedical Recent Developments/Updates
 Table 150. Helcomin Company Information
 Table 151. Helcomin Description and Business Overview
 Table 152. Helcomin Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Helcomin Needle-free Drug Injectors Product
 Table 154. Helcomin Recent Developments/Updates
 Table 155. Nugen Medical Company Information
 Table 156. Nugen Medical Description and Business Overview
 Table 157. Nugen Medical Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Nugen Medical Needle-free Drug Injectors Product
 Table 159. Nugen Medical Recent Developments/Updates
 Table 160. Lepu Medical Company Information
 Table 161. Lepu Medical Description and Business Overview
 Table 162. Lepu Medical Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Lepu Medical Needle-free Drug Injectors Product
 Table 164. Lepu Medical Recent Developments/Updates
 Table 165. Beijing Quinovare Company Information
 Table 166. Beijing Quinovare Description and Business Overview
 Table 167. Beijing Quinovare Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 168. Beijing Quinovare Needle-free Drug Injectors Product
 Table 169. Beijing Quinovare Recent Developments/Updates
 Table 170. Qingdao Zhonghui Health Industrial Group Company Information
 Table 171. Qingdao Zhonghui Health Industrial Group Description and Business Overview
 Table 172. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 173. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product
 Table 174. Qingdao Zhonghui Health Industrial Group Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Needle-free Drug Injectors Distributors List
 Table 178. Needle-free Drug Injectors Customers List
 Table 179. Needle-free Drug Injectors Market Trends
 Table 180. Needle-free Drug Injectors Market Drivers
 Table 181. Needle-free Drug Injectors Market Challenges
 Table 182. Needle-free Drug Injectors Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Needle-free Drug Injectors
 Figure 2. Global Needle-free Drug Injectors Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Needle-free Drug Injectors Market Share by Type: 2025 & 2032
 Figure 4. Powder Injections Product Picture
 Figure 5. Liquid Injections Product Picture
 Figure 6. Depot or Projectile Injection Product Picture
 Figure 7. Global Needle-free Drug Injectors Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Needle-free Drug Injectors Market Share by Application: 2025 & 2032
 Figure 9. Vaccine Delivery
 Figure 10. Insulin Delivery
 Figure 11. Others
 Figure 12. Global Needle-free Drug Injectors Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Needle-free Drug Injectors Market Size (US$ Million), 2021–2032
 Figure 14. Global Needle-free Drug Injectors Sales (K Units), 2021–2032
 Figure 15. Global Needle-free Drug Injectors Average Price (US$/Unit), 2021–2032
 Figure 16. Needle-free Drug Injectors Report Years Considered
 Figure 17. Needle-free Drug Injectors Sales Share by Manufacturers in 2025
 Figure 18. Global Needle-free Drug Injectors Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Needle-free Drug Injectors Players: Market Share by Revenue in Needle-free Drug Injectors in 2025
 Figure 20. Needle-free Drug Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Needle-free Drug Injectors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Needle-free Drug Injectors Sales Market Share by Country (2021–2032)
 Figure 23. North America Needle-free Drug Injectors Revenue Market Share by Country (2021–2032)
 Figure 24. United States Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Needle-free Drug Injectors Sales Market Share by Country (2021–2032)
 Figure 27. Europe Needle-free Drug Injectors Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Needle-free Drug Injectors Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Needle-free Drug Injectors Revenue Market Share by Region (2021–2032)
 Figure 35. China Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Needle-free Drug Injectors Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Needle-free Drug Injectors Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Needle-free Drug Injectors Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Needle-free Drug Injectors Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Needle-free Drug Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Needle-free Drug Injectors by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Needle-free Drug Injectors by Type (2021–2032)
 Figure 55. Global Needle-free Drug Injectors Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Needle-free Drug Injectors by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Needle-free Drug Injectors by Application (2021–2032)
 Figure 58. Global Needle-free Drug Injectors Price (US$/Unit) by Application (2021–2032)
 Figure 59. Needle-free Drug Injectors Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure